Antivenom Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027 - CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics

The “Antivenom Market” report provides 2021-2027 a detailed market overview based on current and future trends that will determine the profit structure. Market size, demand, supply chain, market growth factors, and future trends. It involves an in-depth study of the current trends leading to this vertical trend in different regions. The report provides important information related to components and factors such as market size, market share, market segmentation, main growth drivers, and market competition. Antivenom market segments are highlighted by type and application, region, and major players. It provides key statistics on the market conditions of major market participants.

“The Antivenom Market is predicted to register a CAGR of 11.9% over the forecast period 2021 – 2027.”

Get a Sample Link of this Report:

https://www.marketintelligencedata.com/reports/520898/global-antivenom-sales-market-report-2021/inquiry?Mode=rukaiyya

Key Competitors of the Antivenom market is:

CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech, MicroPharm

Recent Development:

Merck has acquired 29 companies, including 16 in the last 5 years. A total of 8 acquisitions came from private equity firms. It has also divested 7 assets. Merck’s largest acquisition to date was in 2009 when it acquired Schering-Plough for $41.1B. Its largest disclosed sale occurred in 2009 when it sold Merial to Sanofi SA for $4.0B. Merck has acquired in 10 different US states, and 7 countries. The Company’s most targeted sectors include life science (90%) and information technology (4%).
Pfizer has got41 companies, including 12 in the last 5 years. A total of 12 acquisitions came from private equity firms. It has also divested 16 assets. Pfizer’s largest acquisition to date was in 2000 when it acquired Warner-Lambert Company for $90.2B. Its largest disclosed sale occurred in 2006 when it sold Pfizer Consumer Healthcare to Johnson & Johnson for $16.6B. Pfizer has acquired in 11 different US states, and 8 countries. The Company’s most targeted sectors include life science (90%) and consumer products (6%).

Impact of COVID-19 on the Antivenom Market:

The rise of COVID-19 has tempered showcase improvement; anyhow, the market is consistently choosing up-tempo because of growing lockdowns. The fast increment in CAGR is thanks to the request and extension of this marketplace, which is a practicality to come to pre-pandemic ranges once the large, is gone.

Major Types covered are:

Polyvalent antivenom
Monovalent antivenom

Major Applications covered are:

Non-profit Institutions
Hospitals and Clinic

To Get Report Link:

https://www.marketintelligencedata.com/reports/520898/global-antivenom-sales-market-report-2021?Mode=rukaiyya

will get up-to-date with you within 24hrs and assist you to notice the analysis reports and extra Customization you need.

Key Market Trends

The Polyvalent Anti-venoms Segment is Poised to Register Robust Growth
Polyvalent anti-venoms consist of antibodies that are capable of counteracting a number of homologous venoms from various species/genera. Polyvalent antivenoms have the ability to save the lives of victims of snake envenomation, even when the culprit snake is unknown, in most usual cases and about 80% of the time when a monovalent antivenom cannot be chosen. Due to the obvious advantages that they have, polyvalent anti-venoms are the most preferred anti-venom drug.
Owing to the current COVID-19 situation, the research and development of all the companies are deployed for COVID-19 research, and there has been very little or no research going on in this segment currently, which is going to affect the market growth to a certain extent.

Asia-Pacific is Expected to Retain a Significant Market Share During the Forecast Period

The Asia-Pacific anti-venom market is expected to hold a significant share during the forecast period, owing to the high incidence of snake bites and other venomous bites in countries such as India and Bangladesh. For instance, in 2017, the Journal of the Association of Physicians of India published data stating that around 50,000 people die in India annually, due to venomous snake bites.

Also, the government and non-profit organizations in these regions are focusing on various research for the treatment therapeutics. In April 2018, the Jawaharlal Nehru Tropical Botanical Garden and Research Institute (JNTBGRI) and the University College, Thiruvananthapuram, used extracts from the Bael tree to neutralize the adverse effects of cobra venom; the researchers are now planning to formulate the extract.

Regional market Antivenom (regional production, demand and forecast by country):

South America (Brazil, Argentina, Ecuador, Chile)

Asia Pacific (China, Japan, India, Korea)

Europe (Germany, UK, France, Italy)

Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) And more.

The inquire approximately record considers the past, display, and destiny execution of the global market. The record advances investigations the display aggressive situations, most important trade models, and consequently the possible headways in services with the aid of using crucial gamers inside the upcoming years.

Buy Report Here:

https://www.marketintelligencedata.com/report/purchase/520898?mode=su?Mode=rukaiyya

Report Features:

To project the value and sales volume of the Antivenom market, concerning key regions.
To analyses competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To study and analyses the global Antivenom market size (value & volume) by company, key regions, products, and end-user, breakdown data from The Last Five Years, and forecast to 2027.
To understand the structure of the Antivenom market by identifying its various sub-segments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, industry-specific challenges, and risks).

Report Customization:

The Global Antivenom Market report may be modified to meet your specific business needs. Because we understand what our clients want, we offer 25% customization for any of our MarketIntelligenceData reports at no additional cost to all or any of our clients.

About Us:

Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us:

Irfan Tamboli (Head of Sales) – MARKET INTELLIGENCE DATA

Phone: +1 (704) 266-3234

Mail to: sales@marketintelligencedata.com   

This release was published on openPR.